Luigi Bolondi
机构: Professore ordinario di Medicina Interna
每年引用次数
引用次数
引用: 59,878
H-指数: 104
I10-指数 : 340
出版物: 868
Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders.
L. Bolondi , M. Foli , C. Masci , S. Brillanti
Italian Journal of Gastroenterology and Hepatology 31 ( 2) 130 -134
57
1999
Clinical experience with hepatic resections for hepatocellular carcinoma in patients with cirrhosis.
L. Bolondi , R. Bellusci , G. Gozzetti , W. Grigioni
Surgery gynecology & obstetrics 166 ( 6) 503 -510
61
1988
Intraoperative ultrasonography in surgery for liver tumors.
L. Bolondi , R. Bellusci , G. Gozzetti , A. Mazziotti
Surgery 99 ( 5) 523 -530
79
1986
Doppler US in portal hypertension
L. Bolondi , S. Gaiani , S. Siringo , L. Barbara
JEMU. Journal d'échographie et de médecine par ultrasons 14 ( 6) 322 -323
1993
Duplex Doppler evaluation of cystic veins in pre-hepatic portal hypertension
L. Bolondi , S. Gaiani , L. Barbara
The Italian journal of gastroenterology 20 ( 1) 19 -20
1988
AISF practice guidelines for portal hypertension
C. Merkel , O. Riggio , G. D'Amico , V. Ziparo
Italian Journal of Gastroenterology and Hepatology 31 ( 3) 224 -234
7
1999
Variabilità interosservatore ed interapparecchiatura nella valutazione eco-doppler dell'arteria mesenterica superiore
L. Bolondi , S Gaiani , M Zoli , D Sacerdoti
Giornale Italiano di Ultrasonologia 1995; 6:168
1995
Aberrant FHIT transcripts in hepatocellular carcinoma and liver cirrhosis
L. Gramantieri , L. Masi , S. Brillanti , F. Piscaglia
Hepatology 28(4 PART 2 343
1998
Regression of HCC in patients with liver cirrhosis treated with tamoxifen
C. Virgillito , M. Zammataro , S. Siringo , S. Puglisi
Hepatology 34(4 Pt 2 664
2001
Therapy of hepatocellular carcinoma
L. Bolondi , T. Livraghi , C. Rossi , A. Mazziotti
Gastroenterology International 5 ( 4) 221 -229
1992
F.N.26 EFFICACY OF SUPERSELECTIVE TACE IN TREATMENT OF HCC
E. Terzi , F. Piscaglia , C. Trimarchi , R. Golfieri
Digestive and Liver Disease 42
2010
F.N.27 NOTCH SIGNALLING CONTROLS PROLIFERATION AND SENESCENCE OF HUMAN HEPATOCELLULAR CARCINOMA
M. Minguzzi , C. Giovannini , L. Gramantieri , F. Fornari
Digestive and Liver Disease 42
2010
OC-3 MicroRNA-519d is up-regulated in hepatocellular carcinoma and sensitizes HCC cells to Doxorubicin treatment by targeting CDKN1A/p21
F. Fornari , L. Gramantieri , M. Milazzo , G. Pallocca
Digestive and Liver Disease 43
2011
34 MicroRNA-221 TARGETS PUMA AND SENSITIZES HUMAN HEPATOCELLULAR CARCINOMA CELLS TO DOXORUBICIN TREATMENT
F. Fornari , L. Gramantieri , M. Milazzo , D. Pollutri
Digestive and Liver Disease 42
2010
11 VIRTUAL TOUCH ASSESSMENT OF LIVER CIRRHOSIS IN CHRONIC LIVER DISEASE DURING CONVENTIONAL ULTRASOUND SCANNING
F. Piscaglia , V. Salvatore , R. Di Donato , M. D'Onofrio
Digestive and Liver Disease 42
2010
Percutaneous radio-frequency ablation of small HCC: Factors related to clinical outcome and recurrence of disease
F. Piscaglia , N. Celli , M.A. Zocco , M. Mancini
Digestive and Liver Disease 40 ( 5) A35
2008
Notch3 down-regulation increases the sensitivity of HepG2 liver cells to doxorubicin
C. Giovannini , K.B. Marcu , L. Gramantieri , P. Chieco
Digestive and Liver Disease 40 ( 5)
2008
Incidence of late HCC recurrence after resection remains higher than first HCC: Implications for patients management
A. Cucchetti , F. Piscaglia , L. Benvegnù , E. Caturelli
Digestive and Liver Disease 40 ( 5)
2008
Binding of the doxorubicin-lactosaminated human albumin conjugate to HCC cells is mediated by the drug moieties.
M. Baglioni , L. Fiume , L. Bolondi , C. Farina
Digestive and Liver Disease 40 ( 12) 963 -964
3
2008
Notch signaling pathway regulates P57KIP2 expression in human hepatocellular carcinoma
M. Minguzzi , C. Giovannini , F. Fornari , L. Gramantieri
Digestive and Liver Disease 41 ( 3)
2009